Jennifer A. Carver
2017
In 2017, Jennifer A. Carver earned a total compensation of $2.1M as Chief Operating Officer at La Jolla Pharmaceutical, a 29% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $216,000 |
|---|---|
| Option Awards | $1,455,057 |
| Salary | $370,000 |
| Other | $51,159 |
| Total | $2,092,216 |
Carver received $1.5M in option awards, accounting for 70% of the total pay in 2017.
Carver also received $216K in non-equity incentive plan, $370K in salary and $51.2K in other compensation.
Rankings
In 2017, Jennifer A. Carver's compensation ranked 5,281st out of 14,666 executives tracked by ExecPay. In other words, Carver earned more than 64.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,281 out of 14,666 | 64th |
Division Manufacturing | 1,885 out of 5,770 | 67th |
Major group Chemicals And Allied Products | 559 out of 2,074 | 73rd |
Industry group Drugs | 431 out of 1,730 | 75th |
Industry Biological Products, Except Diagnostic Substances | 79 out of 316 | 75th |
Source: SEC filing on August 22, 2018.
Carver's colleagues
We found four more compensation records of executives who worked with Jennifer A. Carver at La Jolla Pharmaceutical in 2017.